Screener
Maze Therapeutics MAZE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Maze Therapeutics’s reported figures.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's free cash flow?
- Maze Therapeutics (MAZE) reported free cash flow of -$15.16M in Q2 2026.
- How has Maze Therapeutics's free cash flow changed year-over-year?
- Maze Therapeutics's free cash flow increased by 50.2% year-over-year, from -$30.45M to -$15.16M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Maze Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude